| Literature DB >> 30878534 |
Jan R Detrez1, Hervé Maurin2, Kristof Van Kolen2, Roland Willems2, Julien Colombelli3, Benoit Lechat4, Bart Roucourt5, Fred Van Leuven6, Sarah Baatout7, Peter Larsen2, Rony Nuydens2, Jean-Pierre Timmermans8, Winnok H De Vos9.
Abstract
We have exploited whole brain microscopy to map the progressive deposition of hyperphosphorylated tau in intact, cleared mouse brain. We found that the three-dimensional spreading pattern of hyperphosphorylated tau in the brain of an aging Tau.P301L mouse model did not resemble that observed in AD patients. Injection of synthetic or patient-derived tau fibrils in the CA1 region resulted in a more faithful spreading pattern. Atlas-guided volumetric analysis showed a connectome-dependent spreading from the injection site and also revealed hyperphosphorylated tau deposits beyond the direct anatomical connections. In fibril-injected brains, we also detected a persistent subpopulation of rod-like and swollen microglia. Furthermore, we showed that the hyperphosphorylated tau load could be reduced by intracranial co-administration of, and to a lesser extent, by repeated systemic dosing with an antibody targeting the microtubule-binding domain of tau. Thus, the combination of targeted seeding and in toto staging of tau pathology allowed assessing regional vulnerability in a comprehensive manner, and holds potential as a preclinical drug validation tool.Entities:
Keywords: Alzheimer's disease; Hyperphosphorylated tau; Light-sheet microscopy; Microglia; Tau; Tau.P301L; Tissue clearing; Whole brain imaging
Mesh:
Substances:
Year: 2019 PMID: 30878534 DOI: 10.1016/j.nbd.2019.03.010
Source DB: PubMed Journal: Neurobiol Dis ISSN: 0969-9961 Impact factor: 5.996